AKT1 and cancer: Here, the pathways ‘phosphatidylinositide 3 kinase (PI3K)/AKT activation’, ‘phosphatidylinositol (3,4,5) triphosphate (PI3P) activates AKT signalling’, ‘PI3K/AKT Signalling in Cancer’, and ‘Constitutive Signalling by Aberrant PI3K in Cancer’ were found to be significantly enriched.